Article
Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding.
Orphanet journal of rare diseases - 13 Jul 2020
Beckman Joan D, Li Quefeng, Hester Samuel T, Leitner Ofri, Smith Karen L, Kasthuri Raj S
Abstract excerpt
BACKGROUND: Hereditary Hemorrhagic Telangiectasia (HHT) is a rare inherited disorder characterized by development of mucocutaneous telangiectases and visceral organ arteriovenous malformations, which can lead to recurrent, spontaneous bleeding and development of iron deficiency anemia. The primary objective of this study was to ascertain the relationship between epistaxis severity scores (ESS), laboratory values,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.